Provided by Tiger Trade Technology Pte. Ltd.

ELECTRA THERAPEUTICS INC

13.25
-1.7500-11.67%
Post-market: 13.520.2700+2.04%19:59 EDT
Volume:5.12M
Turnover:74.57M
Market Cap:809.58M
PE:- -
High:15.50
Open:15.00
Low:13.25
Close:15.00
52wk High:15.50
52wk Low:13.25
Shares:61.10M
Float Shares:21.67M
Volume Ratio:- -
T/O Rate:23.65%
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Company Profile

Company Name:
ELECTRA THERAPEUTICS INC
Exchange:
NASDAQ
Establishment Date:
2018
Employees:
- -
Office Location:
230 E Grand Avenue,Suite S-100,South San Francisco,California,United States
Zip Code:
94080
Fax:
- -
Introduction:
Electra Therapeutics, Inc. is a late clinical-stage biopharmaceutical company focused on developing novel precision medicines for immune-mediated diseases and cancer. The company targets signal regulatory proteins (SIRP), a family of cell surface receptors expressed on specific immune cell populations, to selectively deplete disease-driving cells while preserving normal immune function. Founded in 2018 and headquartered in South San Francisco, CA.

Directors

Name
Position
Nancy Stagliano
Chairman of the Board and Director
Quehuong Dong
Chief Executive Officer and Director and President
Beth Seidenberg
Director
Carl L. Gordon
Director
Matthew Fust
Director
Thomas Geninatti
Director

Shareholders

Name
Position
Quehuong Dong
Chief Executive Officer and Director and President
Chris Clark
Chief Financial Officer
Gary S. Koe
Chief Technical Officer
Graham Parry
Chief Scientific Officer
Kim Hien Dao
Chief Medical Officer